Full name
"SOL-MILLENNIUM EUROPE" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
49.20.Z - Rail freight transport
49.41.Z - Road freight transport
51.21.Z - Air freight transport
52.10.B - Warehousing and storage of other goods
70.10.Z - Head office activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 37,7 | 0,2 | 1,3 | 589,2 |
EBITDA | 36,7 | 0,1 | 4,7 | 5751,2 |
Short time liabilities | 25,5 | 14,4 | 6 | -58 |
Equity capital | 37,8 | 36,1 | 36,5 | 1,1 |
Operating profit (EBIT) | 36,5 | -0,2 | 4,4 | 2326,9 |
Assets | 68,2 | 53,4 | 44,1 | -17,4 |
Net profit (loss) | 30,2 | -0,6 | 0,4 | 164 |
Cash | 1,6 | 9,5 | 9,1 | -4,1 |
Net income from sale | 198,3 | 85,8 | 80,9 | -5,7 |
Liabilities and provisions for liabilities | 30,4 | 17,3 | 7,6 | -56 |
Working assets | 65,8 | 51,4 | 42 | -18,3 |
Depreciation | 0,2 | 0,3 | 0,3 | 25,5 |
% | % | % | p.p. | |
Profitability of capital | 80 | -1,7 | 1,1 | 2,8 |
Equity capital to total assets | 55,4 | 67,6 | 82,8 | 15,2 |
Gross profit margin | 19 | 0,2 | 1,6 | 1,4 |
EBITDA Margin | 18,5 | 0,1 | 5,8 | 5,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 47 | 61 | 27 | -34 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane